Disease characteristics, survival outcomes, and tumor molecular landscape in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) harboring CDK12 alterations (CDK12a) receiving intensified androgen deprivation therapy (ADTi).
- Resource Type
- Article
- Authors
- Hage Chehade, Chadi; Gebrael, Georges; Srivastava, Ayana; Tripathi, Nishita; Sayegh, Nicolas; Mathew Thomas, Vinay; Galarza Fortuna, Gliceida; Chigarira, Beverly; Nordblad, Blake; Campbell, Patrick; Tandar, Clara; Li, Haoran; Maughan, Benjamin L.; Agarwal, Neeraj; Swami, Umang
- Source
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p189-189, 235p
- Subject
- Language
- ISSN
- 0732183X